The global Cancer immunotherapy drugs Market size is expected to reach USD 222.48 Billion in 2028, registering a CAGR of 10.1% over the forecast period, according to a new report by Reports and Data. Key factors driving cancer immunotherapy drugs market revenue growth are increasing adoption of immunotherapy drugs over conventional treatments, increasing prevalence of cancer, increasing investments for development of biosimilars and monoclonal antibodies, along with a favorable drug approval scenario.

A paradigm shift away from standard chemotherapies and toward immunotherapies is paving the way for the cancer immunotherapy drugs business to thrive. Immuno-oncology has shown promise in terms of reduced toxicity and increased survival rates. Patients will be more likely to undertake immunotherapy if the efficacy and effectiveness of stem cell therapies improves.

According to a survey published in 2018, the global cancer burden has increased to 18.1 million new cases and 9.6 million deaths. Several government agencies and cancer research institutes have responded by investing in the research and development of various forms of cell therapies for cancer treatment.

Top Companies Profiled in the Report Include:

Bristol-Myers Squibb, Novartis International Ag, Celgene Corporation, Amgen Inc., Merck Co. Inc., Janssen Global Services, LLC, Seattle Genetics Inc, Printegra, Gristone Oncology, Inc, Pfizer Inc. has been profiled in the report. They are significant market players.

Cancer immunotherapy drugs Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Major Highlights of the Cancer immunotherapy drugss Market Report:

• In May 2020, the National Institute for Health and Care Excellence in the U.K. approved Tecentriq, immunotherapy by Roche, for patients with triple-negative breast cancer.
• On the basis of technology, the monoclonal antibodies segment accounted for the largest market revenue share in cancer immunotherapy drugs market in 2020. This market dominance is on account of rise in product approvals to fulfill the demands of the growing need for cancer immunotherapy drugs.
• On the basis of application, the lung cancer segment is expected to contribute significantly to the cancer immunotherapy drugs market revenue share. The rapid development can be linked to the rising number of smokers worldwide, as well as the widespread use of tobacco products such as electronic cigarettes, which has resulted in an increase in cancer cases.
• On the basis of end-use, the hospitals clinics segment accounted for the largest market share in 2020. The robust growth is a result of increased patient preference for cancer immunotherapy drugs, as they offer cutting-edge treatments to boost the immune system to fight cancer.
• North America dominated the cancer immunotherapy drugs market and expected to register a CAGR of 14.1% over the forecast period. The growth can be attributed to rising technological advancements in the medical field such as the development of CRISPR for cancer treatment in the region.
• The cancer immunotherapy drugs market in Europe is estimated to exhibit a CAGR of 13% over the forecast period on account of the introduction of favorable medical reimbursement policies in the region.
• The cancer immunotherapy drugs market in the Asia Pacific is expected to register a CAGR of 17.2% over the forecast period on account of the presence of a massive patient pool suffering from various types of cancer in India and China.
• Key players in the global cancer immunotherapy drugs market are Bristol-Myers Squibb, Celgene Corporation, Novartis International Ag, Amgen Inc., Merck Co. Inc., Seattle Genetics Inc, Printegra, Janssen Global Services, LLC, Gristone Oncology, and Inc, Pfizer Inc., among others.

Additionally, the report consists a detailed analysis of the segmentation of the Cancer immunotherapy drugss Market based on product types and end-use/application offered in the Cancer immunotherapy drugss Market –

Technology Outlook (Revenue, USD Billion; 2020 – 2028)

• Monoclonal Antibodies
• Vaccines
• Checkpoint Inhibitors
• Cell Therapies
• Immune System Modulators
• Adoptive Cell Transfer
• Cytokines
• Others

Application Outlook (Revenue, USD Billion; 2020 – 2028)

• Head Neck Cancer
• Blood Cancers
• Liver Cancer
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Melanoma
• Others

End Use Outlook (Revenue, USD Billion; 2020 – 2028)

• Cancer Research Centers
• Hospitals
• Clinics
• Others

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Request for Customization this report - https://www.reportsanddata.com/request-customization-form/1550